[{"NetIncomeLoss_1_Q1_USD":1115200000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"MarketableSecuritiesCurrent_0_Q1_USD":2065900000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q1_USD":1455200000.0,"LongTermDebtFairValue_0_Q1_USD":1803000000.0,"EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_0_Q1_USD":40000000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":117900000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":16200000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-1059000000.0,"AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_1_Q1_USD":-446700000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":66400000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":6200000.0,"AssetsCurrent_0_Q1_USD":10055100000.0,"OtherNoncashIncomeExpense_1_Q1_USD":115700000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":405600000.0,"FinanceLeaseLiabilityNoncurrent_0_Q1_USD":0.0,"TreasuryStockShares_0_Q1_shares":17104177.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":93900000.0,"TreasuryStockValue_0_Q1_USD":6935300000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":971200000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":4607200000.0,"Assets_0_Q1_USD":17772200000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-13300000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-13100000.0,"Liabilities_0_Q1_USD":5795200000.0,"OtherAssetsNoncurrent_0_Q1_USD":145700000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":742900000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q1_USD":6200000.0,"EarningsPerShareBasic_1_Q1_USD":10.58,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q1_USD":143900000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":110500000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":154900000.0,"AccountsReceivableNetCurrent_0_Q1_USD":4173000000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":137800000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q1_USD":0.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-34700000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q1_USD":2541300000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":67400000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.11,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-366400000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q1_USD":6200000.0,"CostsAndExpenses_1_Q1_USD":1416000000.0,"RestrictedCash_0_Q1_USD":12500000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":416300000.0,"IncreaseDecreaseInInventories_1_Q1_USD":252800000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q1_USD":1492200000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":1102100000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":1437900000.0,"ShareBasedCompensation_1_Q1_USD":130900000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":95000000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":135600000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":668500000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":576200000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":105400000.0,"PaymentsToAcquireProductiveAssets_1_Q1_USD":115300000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q1_USD":2065900000.0,"MarketableSecuritiesNoncurrent_0_Q1_USD":3543700000.0,"LiabilitiesCurrent_0_Q1_USD":3217800000.0,"NonoperatingIncomeExpense_1_Q1_USD":140300000.0,"InterestExpense_1_Q1_USD":14600000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":1450400000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":213600000.0,"LongTermDebtNoncurrent_0_Q1_USD":1978900000.0,"IncreaseDecreaseInDeferredIncomeTaxes_1_Q1_USD":-10100000.0,"AccountsPayableCurrentAndNoncurrent_0_Q1_USD":542900000.0,"AdditionalPaidInCapital_0_Q1_USD":6887800000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q1_USD":1455200000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":75600000.0,"OtherInventoryNetOfReserves_0_Q1_USD":499400000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":3262600000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":154500000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":29300000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":1360000000.0,"EarningsPerShareDiluted_1_Q1_USD":10.09,"DeferredIncomeTaxAssetsNet_0_Q1_USD":765100000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":50000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":2528700000.0,"OperatingIncomeLoss_1_Q1_USD":1112700000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":1253000000.0,"PaymentsForRepurchaseOfCommonStock_1_Q1_USD":306900000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1_Q1_USD":200000.0,"InventoryNet_0_Q1_USD":2164700000.0,"StockRepurchasedDuringPeriodValue_1_Q1_USD":323500000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":464900000.0,"OtherOperatingIncomeExpenseNet_1_Q1_USD":40500000.0,"PreferredStockValue_0_Q1_USD":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":30000000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_0_Q1_USD":0.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":571500000.0,"FinanceLeaseLiabilityCurrent_0_Q1_USD":717800000.0,"StockholdersEquity_0_Q1_USD":11977000000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":27000000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":4584100000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":12008200000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-756900000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":58300000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":17772200000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-143600000.0,"Ticker":"REGN","CIK":"872589","name":"REGENERON PHARMACEUTICALS, INC.","OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"77738004554.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20210506"}]